Bevacizumab-Therapie im „Off-label use“ bei der neovaskulären altersabhängigen Makuladegeneration
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/content/pdf/10.1007/s00347-006-1351-6.pdf
Reference10 articles.
1. Avery RL, Pieramici DJ, Rabena MD et al. (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113(3): 363–372
2. Folkman J (1971) Tumor Angiogenesis: Therapeutic implications. New Eng J Med 285: 1185–1186
3. Gonzales CR (2005) VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 25(7): 815–827
4. Gragoudas ES, Adamis AP, Cunningham ET et al. (2004) VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27): 2805–2816
5. Ishida S, Usui T, Yamashiro K et al. (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198(3): 483–489
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization;Ophthalmology;2008-10
2. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study;Acta Ophthalmologica;2008-07-22
3. Intraokulare Bevacizumab-Injektionen bei seltenen Indikationen – zwei Kasuistiken;Der Ophthalmologe;2008-07-06
4. Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD;Der Ophthalmologe;2007-07-25
5. Intraokulare Injektion von Bevacizumab – Eine mögliche Therapie der sekundären CNV bei „angioid streaks“;Der Ophthalmologe;2007-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3